Holly Siegfried

DNP Doctor of Nursing Practice,  Mayo Clinic - Rochester 

Location: Africa

Consulting Services

Sales and Marketing Scientific Writing

Areas Of Interest

Rat, Inbred F344 Echo Reaction Dietilretard Requirement, Nutritional Dissent and Disputes Ceratozamias Domain, TPR Physical Exercises Protein Kinase C-theta Calcium Signaling Supplementary Feedings Parkinson Disease, Postencephalitic Figwort Betonies UK14,30418 Polysaccharide Vaccine, Meningococcal States, Neurotic Anxiety raf MAP Kinase Kinase Kinases System, Obesity Management Anti-CCP Expeflen Acetaldehyde Dehydrogenase Antagonists Bedding and Linens Ionophores, Proton Pilocarpine Nitrate Antarctic Tundra Melanocortin Receptor 2 Effects, Androgen Dyssynergia Cerebellaris Myoclonica Biopolymer Atresia, Anorectal Angiotensin II, 1-Asparagine-5-valine Split-Brain Procedures Dyssomnias Tobramycin Louse, Sucking Test, Nociception Gonadotropin-Releasing Hormone Archiving, Data Pancreatic Insufficiency, Exocrine

Professional Narrative

Dr. Holly Siegfried was born in DuBois, Pennsylvania and is a graduate of Villanova University. He obtained his medical degree at Thomas Jefferson University in Philadelphia. His residency was at Thomas Jefferson and its affiliated Wills Eye Hospital, and he completed his training with fellowships at the University of Connecticut incataract andcorneal surgery.

Dr. Siegfried has thirty years’ experience in ophthalmic surgery,withspecialinterestin cataract surgery,corneal transplantation,andlaserrefractiveprocedures.Heisa founding member of Precision LASIK Group, Chief of Ophthalmology at The Hospital ofCentral Connecticut,andco-medical director of the Connecticut eye bank.


Employment

Director Medicine, Amgen 1993
Director Medicine, Mayo Clinic 1998

Education

Doctor of medicine, Harvard Medical School 2010
Doctor of medicine, Perelman School of Medicine 1997

Referees


Publications

Roberts TC, Langer R, Wood MJA. Advances in oligonucleotide drug delivery. Nat Rev Drug Discov. 2020 Oct;19(10):673-694. doi: 10.1038/s41573-020-0075-7. Epub 2020 Aug 11. PMID: 32782413; PMCID: PMC7419031.

Mitchell MJ, Billingsley MM, Haley RM, Wechsler ME, Peppas NA, Langer R. Engineering precision nanoparticles for drug delivery. Nat Rev Drug Discov. 2021 Feb;20(2):101-124. doi: 10.1038/s41573-020-0090-8. Epub 2020 Dec 4. PMID: 33277608; PMCID: PMC7717100.

Reichmuth AM, Oberli MA, Jaklenec A, Langer R, Blankschtein D. mRNA vaccine delivery using lipid nanoparticles. Ther Deliv. 2016;7(5):319-34. doi: 10.4155/tde-2016-0006. Erratum in: Ther Deliv. 2016 Jun;7(6):411. PMID: 27075952; PMCID: PMC5439223.

Tang Z, Kong N, Zhang X, Liu Y, Hu P, Mou S, Liljeström P, Shi J, Tan W, Kim JS, Cao Y, Langer R, Leong KW, Farokhzad OC, Tao W. A materials-science perspective on tackling COVID-19. Nat Rev Mater. 2020;5(11):847-860. doi: 10.1038/s41578-020-00247-y. Epub 2020 Oct 14. PMID: 33078077; PMCID: PMC7556605.


Grants,Awards and Certifications

Grants :

No Grants Mentioned !!

Awards & Prizes :


Languages

Language Proficiency :

Translation Services :